AI to assist in the diagnosis of dementia
The Government through has announced, the located at the 爆料王, Brain and Mind Centre, is one of six companies with promising digital health solutions that will share in up to $3.75 million in funding to bridge crucial research gaps.听
SNAC is one of the world鈥檚 largest imaging providers using artificial intelligence to better monitor brain disease with its听state-of-the-art facilities.听
iQ-Solutions is SNAC鈥檚 flagship product which provides precise analysis of the brain through MRI imaging. It will give doctors a real-time view of any changes that can then be managed more readily.
It is challenging to turn a scientific discovery into a medical product that鈥檚 ready for clinical use. This is the case for many digital health technologies 鈥� like iQ-Solutions 鈥� which have the potential to transform the health system.
The ANDHealth+ program will provide us with tailored mentorship, access to industry leaders and substantive funding to bring our innovative suite of software-based medical devices to market, supporting both patients with disabling neurological conditions and the clinicians involved in their care.
MS Base Imaging Repository
In 2020, SNAC alongside the Computational Neuroimaging research team headed by Professor Michael Barnett and Dr Chenyu Wang launched , the world鈥檚 largest MS Imaging repository. MSBIR uses iQ-Solutions to better enable researchers and clinicans around the world to asccess the imaging repository for research purposes. This global access helps enable research in dementia and MS.
The Government announced its plan to invest $20 million to commercialise digital health research, taking it from the lab and putting it in the hands of patients and their health team. For the Sydney Neuroimaging Analysis Centre (SNAC) this will go towards their mission to in using artificial intelligence to unlock the secrets of neurological disorders like multiple sclerosis and dementia.
ANDHealth+
ANDHealth+ works with small to medium companies through the early-stage development of technologies with commercial potential.
听
To realise the potential of Australia鈥檚 world-class digital health research, ANDHealth+ received $19.75 million through the Medical Research Future Fund鈥檚 (MRFF) Medical Research Commercialisation initiative.
